Oncolix, Inc. — Form D

Oncolix, Inc. of HOUSTON, TX, a company, filed a Form D exempt-offering notice with the SEC on 2017-02-06. The offering totals $5.0M, of which $250K was reported sold. Industry: Biotechnology.

Offering

• Filed: 2017-02-06
• Form: D
• Accession: 0001574061-17-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $5.0M
• Amount sold: $250K
• Remaining: $4.8M
• Minimum investment: $50K
• Investors: 1
• Date of first sale: 2017-01-20
• Security types: debt
• Revenue range: No Revenues
• SEC file number: 021-280080

Issuer

• Name: Oncolix, Inc.
• CIK: 0001574061
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Address: 14405 WALTERS ROAD, SUITE 780, HOUSTON, TX, 77014
• Phone: 281-402-3169

Officers, directors & promoters (10)

Other filings by this issuer (6)

More

• CIK 1574061 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search